Gene · 2254
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. | Int J Mol Sci | 2023 | 36768146 | PubTator, text mining | PubMed |
| The miR-100-5p Targets SMARCA5 to Regulate the Apoptosis and Intracellular Survival of BCG in Infected THP-1 Cells. | Cells | 2023 | 36766816 | PubTator, text mining | PubMed |
| Using single cell atlas data to reconstruct regulatory networks. | Nucleic Acids Res | 2023 | 36762475 | PubTator, text mining | PubMed |
| Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration. | J Biol Eng | 2023 | 36759827 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Affect Tumor Metabolism and Immune Microenvironment in Gastric Cancer and Identification of Its Characteristic Genes. | J Oncol | 2023 | 36755806 | PubTator, text mining | PubMed |
| Transcriptomics-proteomics Integration reveals alternative polyadenylation driving inflammation-related protein translation in patients with diabetic nephropathy. | J Transl Med | 2023 | 36747266 | PubTator, text mining | PubMed |
| Osteoarthritis: pathogenic signaling pathways and therapeutic targets. | Signal Transduct Target Ther | 2023 | 36737426 | PubTator, text mining | PubMed |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. | Cell | 2023 | 36736301 | PubTator, text mining | PubMed |
| Sertoli cells-derived exosomal miR-30a-5p regulates ubiquitin E3 ligase Zeb2 to affect the spermatogonial stem cells proliferation and differentiation. | Reprod Toxicol | 2023 | 36731640 | PubTator, text mining | PubMed |
| Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids. | Proc Natl Acad Sci U S A | 2023 | 36724260 | PubTator, text mining | PubMed |
| Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. | J Clin Invest | 2023 | 36719370 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer. | BMC Cancer | 2023 | 36717783 | PubTator, text mining | PubMed |
| Distinct COPD subtypes in former smokers revealed by gene network perturbation analysis. | Respir Res | 2023 | 36698131 | PubTator, text mining | PubMed |
| Comprehensive overview of microRNA function in rheumatoid arthritis. | Bone Res | 2023 | 36690624 | PubTator, text mining | PubMed |
| Ubiquitin protein E3 ligase ASB9 suppresses proliferation and promotes apoptosis in human spermatogonial stem cell line by inducing HIF1AN degradation. | Biol Res | 2023 | 36683111 | PubTator, text mining | PubMed |
| Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. | J Exp Clin Cancer Res | 2023 | 36683050 | PubTator, text mining | PubMed |
| Application of an in silico approach identifies a genetic locus within ITGB2, and its interactions with HSPG2 and FGF9, to be associated with anterior cruciate ligament rupture risk. | Eur J Sport Sci | 2023 | 36680346 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
| Primary and Metastatic Cutaneous Melanomas Discriminately Enrich Several Ligand-Receptor Interactions. | Life (Basel) | 2023 | 36676129 | PubTator, text mining | PubMed |
| The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions. | J Neuroinflammation | 2023 | 36650549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2254/papers?page=20